Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -0.15% | -7.55% | -21.69% |
May. 09 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 36.1M | Sales 2025 * | 47.4M | Capitalization | 88.11M |
---|---|---|---|---|---|
Net income 2024 * | 1M | Net income 2025 * | - | EV / Sales 2024 * | 2.44 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
31.2
x | P/E ratio 2025 * |
14.3
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.75% |
Latest transcript on Eton Pharmaceuticals, Inc.
1 day | -0.15% | ||
1 week | -7.55% | ||
Current month | -2.00% | ||
3 months | -22.22% | ||
6 months | -10.68% | ||
Current year | -21.69% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 17-05-31 |
James Gruber
DFI | Director of Finance/CFO | 52 | 22-04-10 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 17-05-31 | |
Paul Maier
BRD | Director/Board Member | 76 | 17-09-13 |
Norbert Riedel
CHM | Chairman | 66 | 17-09-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.43 | -0.15% | 139,532 |
24-05-09 | 3.435 | -7.66% | 153,225 |
24-05-08 | 3.72 | 0.00% | 57,823 |
24-05-07 | 3.72 | -0.80% | 41,132 |
24-05-06 | 3.75 | +1.08% | 38,278 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.69% | 88.11M | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ETON Stock